Stay updated with breaking news from Dinutuximab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BeiGene, Ltd. (NASDAQ:BGNE; HKEX:06160) and EUSA Pharma (UK), Ltd. today announced that the China National Medical Products Administration (NMPA) has granted QARZIBA(dinutuximab beta) conditional approval ....